Policy Impact Analysis - 117/S/3489

Bill Overview

Title: A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.

Description: This bill directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential. Specifically, the NIH must establish or continue a multidisciplinary program for supporting research centers to advance the discovery and development of medical products to prevent, treat, and diagnose such viruses.

Sponsors: Sen. Burr, Richard [R-NC]

Target Audience

Population: People worldwide potentially affected by pandemics

Estimated Size: 330000000

Reasoning

Simulated Interviews

Healthcare researcher (Los Angeles, CA)

Age: 34 | Gender: female

Wellbeing Before Policy: 6

Duration of Impact: 10.0 years

Commonness: 5/20

Statement of Opinion:

  • This policy is crucial for future pandemic preparedness.
  • As a researcher, I see the direct benefits in advancing medical products.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 7 6
Year 2 7 6
Year 3 8 6
Year 5 8 6
Year 10 9 7
Year 20 9 7

Public Health Officer (New York, NY)

Age: 45 | Gender: male

Wellbeing Before Policy: 7

Duration of Impact: 10.0 years

Commonness: 4/20

Statement of Opinion:

  • The policy could strengthen our response to future pandemics.
  • Increased research is vital for pandemic preparedness.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 8 7
Year 2 8 7
Year 3 9 7
Year 5 9 8
Year 10 9 8
Year 20 9 8

Teacher (Chicago, IL)

Age: 60 | Gender: female

Wellbeing Before Policy: 5

Duration of Impact: 5.0 years

Commonness: 8/20

Statement of Opinion:

  • I hope this policy leads to better protections in schools.
  • Pandemics significantly disrupt education environments.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 5
Year 2 6 5
Year 3 7 5
Year 5 7 6
Year 10 8 6
Year 20 8 7

Entrepreneur (Houston, TX)

Age: 50 | Gender: male

Wellbeing Before Policy: 6

Duration of Impact: 10.0 years

Commonness: 6/20

Statement of Opinion:

  • Increased research can lead to better business opportunities.
  • Health-related disruptions impact business sustainability.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 7 6
Year 2 8 6
Year 3 8 6
Year 5 9 7
Year 10 9 7
Year 20 9 8

Graduate Student (Portland, OR)

Age: 24 | Gender: other

Wellbeing Before Policy: 7

Duration of Impact: 8.0 years

Commonness: 7/20

Statement of Opinion:

  • This policy aligns with what I'm studying and it's promising.
  • Interdisciplinary research is key to tackling complex health issues.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 7 7
Year 2 8 7
Year 3 8 7
Year 5 8 7
Year 10 9 8
Year 20 9 8

Software Developer (Miami, FL)

Age: 38 | Gender: male

Wellbeing Before Policy: 6

Duration of Impact: 5.0 years

Commonness: 7/20

Statement of Opinion:

  • Enhanced research will spur innovation in health tech.
  • Policy could indirectly benefit tech businesses through research funding.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 6
Year 2 7 6
Year 3 7 6
Year 5 7 6
Year 10 8 6
Year 20 8 7

Nurse (Columbus, OH)

Age: 29 | Gender: female

Wellbeing Before Policy: 7

Duration of Impact: 10.0 years

Commonness: 6/20

Statement of Opinion:

  • This policy could improve healthcare responses in future crises.
  • Preparedness is crucial to protecting patients and healthcare workers.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 8 7
Year 2 8 7
Year 3 9 7
Year 5 9 8
Year 10 9 8
Year 20 9 8

Retail Manager (Austin, TX)

Age: 53 | Gender: female

Wellbeing Before Policy: 5

Duration of Impact: 10.0 years

Commonness: 8/20

Statement of Opinion:

  • Research could prevent future economic instabilities.
  • Health crises have drastic effects on retail and consumers.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 5
Year 2 7 5
Year 3 7 6
Year 5 7 6
Year 10 8 7
Year 20 8 7

Retired (Phoenix, AZ)

Age: 66 | Gender: male

Wellbeing Before Policy: 6

Duration of Impact: 5.0 years

Commonness: 9/20

Statement of Opinion:

  • I hope this policy prepares us for the next pandemic.
  • Older populations need reassurance of better future healthcare responses.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 6
Year 2 7 6
Year 3 7 6
Year 5 8 7
Year 10 8 7
Year 20 9 7

Biotech Executive (Denver, CO)

Age: 41 | Gender: female

Wellbeing Before Policy: 8

Duration of Impact: 10.0 years

Commonness: 3/20

Statement of Opinion:

  • The policy could accelerate innovation in biotech.
  • Industry partnerships with NIH could yield significant advancements.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 8 8
Year 2 9 8
Year 3 9 8
Year 5 9 8
Year 10 10 9
Year 20 10 9

Cost Estimates

Year 1: $1000000000 (Low: $900000000, High: $1200000000)

Year 2: $1050000000 (Low: $950000000, High: $1250000000)

Year 3: $1100000000 (Low: $1000000000, High: $1300000000)

Year 5: $1200000000 (Low: $1100000000, High: $1400000000)

Year 10: $1400000000 (Low: $1300000000, High: $1600000000)

Year 100: $2000000000 (Low: $1800000000, High: $2200000000)

Key Considerations